US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Prothena Corporation PLC (PRTA)
Prothena Corporation PLC (PRTA) ニュース

PRTA

Prothena (PRTA)

Prothena Corporation PLC

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PRTA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/04	09 : 45	Edgar (US Regulatory)	Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:PRTA	Prothena Corporation PLC
2024/12/31	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/12/31	06 : 05	Business Wire	Prothena Announces Board of Directors Update	NASDAQ:PRTA	Prothena Corporation PLC
2024/12/19	15 : 05	Business Wire	Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease	NASDAQ:PRTA	Prothena Corporation PLC
2024/11/13	21 : 00	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:PRTA	Prothena Corporation PLC
2024/11/13	06 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/11/13	06 : 05	Business Wire	Prothena Reports Third Quarter 2024 Financial Results and Business Highlights	NASDAQ:PRTA	Prothena Corporation PLC
2024/11/06	06 : 05	Business Wire	Prothena to Report Third Quarter 2024 Financial Results on November 12	NASDAQ:PRTA	Prothena Corporation PLC
2024/10/04	07 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/10/04	07 : 57	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/09/28	05 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/09/28	05 : 05	Business Wire	Prothena Announces Leadership Team Updates	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/30	05 : 05	Business Wire	Prothena to Participate in Upcoming Healthcare Conferences	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/09	06 : 13	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/09	05 : 14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/09	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/09	05 : 05	Business Wire	Prothena Reports Second Quarter 2024 Financial Results and Business Highlights	NASDAQ:PRTA	Prothena Corporation PLC
2024/08/02	05 : 05	Business Wire	Prothena to Report Second Quarter 2024 Financial Results on August 8	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/29	05 : 05	Business Wire	Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/18	05 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/09	05 : 19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/09	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/09	05 : 05	Business Wire	Prothena Reports First Quarter 2024 Financial Results and Business Highlights	NASDAQ:PRTA	Prothena Corporation PLC
2024/05/02	05 : 05	Business Wire	Prothena to Report First Quarter 2024 Financial Results on May 8	NASDAQ:PRTA	Prothena Corporation PLC
2024/04/16	05 : 05	Business Wire	Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/06	11 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC
2024/03/06	11 : 01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PRTA	Prothena Corporation PLC

Showing the most relevant articles for your search:NASDAQ:PRTA

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Sterling

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約